The regulation of biosimilars
A follow-up from the CASTOR trial evaluating daratumumab with bortezomib for the treatment of MM
Which is the best combination therapy in relapsed and refractory multiple myeloma?
Big data on efficacy and toxicity levels for ibrutinib in CLL
Understanding the drivers behind disease with the 100,000 Genomes Project